Oncology

Solid tumors, hematologic malignancies, and immuno-oncology therapies targeting cancer cell survival and proliferation.

Provisional & emerging programs (56)Early clinical pipeline & single-asset indications
Colorectal Cancer
58 assets· 4 indications
Solid Tumors
53 assets· 5 indications
Ovarian Cancer
38 assets
Prostate Cancer
34 assets
Melanoma
31 assets· 3 indications
Hepatocellular Carcinoma
29 assets
Renal Cell Carcinoma
29 assets· 2 indications
Gastric Cancer
26 assets
Non-Hodgkin Lymphoma
26 assets· 9 indications
Bladder / Urothelial Cancer
25 assets· 2 indications
Cervical Cancer
21 assets
Small Cell Lung Cancer
21 assets
Biliary Tract Cancer
17 assets· 3 indications
Chronic Lymphocytic Leukemia
17 assets· 2 indications
Glioblastoma
17 assets· 3 indications
Metastatic Castration-Resistant Prostate Cancer
17 assets
Pancreatic Ductal Adenocarcinoma
17 assets
Endometrial Cancer
16 assets
Diffuse Large B-Cell Lymphoma
15 assets· 2 indications
Head and Neck Squamous Cell Carcinoma
15 assets
Bladder Cancer
14 assets
Pancreatic Cancer
13 assets
Follicular Lymphoma
12 assets
Myelodysplastic Syndromes
12 assets· 2 indications
Esophageal Cancer
11 assets
Glioma
11 assets
Mantle Cell Lymphoma
8 assets
Nasopharyngeal Carcinoma
7 assets
Acute Lymphoblastic Leukemia
6 assets
Myelofibrosis
6 assets· 2 indications
Soft Tissue Sarcoma
6 assets· 4 indications
Polycythemia Vera
5 assets
Cutaneous T-Cell Lymphoma
4 assets
Merkel Cell Carcinoma
4 assets
Uveal Melanoma
4 assets· 2 indications
Chronic Myeloid Leukemia
3 assets· 2 indications
Essential Thrombocythemia
3 assets
Gastrointestinal Stromal Tumor
3 assets
Systemic Mastocytosis
3 assets
Brain Cancer
2 assets
Hematologic Malignancies
2 assets
Anal Cancer
1 asset
Bone Cancer
1 asset
Bone Metastases from Solid Tumors
1 asset
Brain Metastases
1 asset
Cancer Cachexia
1 asset
Chemotherapy-Induced Nausea and Vomiting
1 asset
Classical Hodgkin Lymphoma
1 asset
Gastroenteropancreatic Neuroendocrine Tumors
1 asset
Neuroblastoma
1 asset
Oropharyngeal Cancer
1 asset
Rectal Cancer
1 asset
Waldenstrom's Macroglobulinemia
1 asset
B-Cell Lymphoma
0 assets
Central Nervous System Tumors
0 assets
Neuroendocrine Tumors
0 assets

All assets in Oncology

← all areas